Precision Diagnostics Recognised Among Malaysia's Top 10 Healthcare BioNexus Status Companies
Precision Diagnostics is proud to announce its recognition as one of Malaysia’s Top 10 Healthcare BioNexus Status Companies, selected from more than 600 BioNexus and Bio-based Accelerator (BBA) companies nationwide.
BioNexus Status is Malaysia’s prestigious accreditation for biotechnology companies that demonstrate innovation, commercial potential, and contributions to the nation’s bioeconomy. Being recognised among the country’s Top 10 Healthcare BioNexus Status Companies further reflects Precision Diagnostics’ leadership in translating genomic science into clinically actionable healthcare solutions.
As precision medicine continues to transform healthcare globally, Precision Diagnostics remains committed to supporting healthcare professionals, hospitals, and individuals through innovative genomic services, including Pharmacogenomics (PGx), Nutrigenomics (NGx), and other precision health technologies. The company continues to collaborate with healthcare institutions, academic partners, and industry stakeholders to accelerate the adoption of precision medicine and improve patient outcomes. leadership in translating genomic science into clinically actionable healthcare solutions.
About BioNexus Status
BioNexus Status is a national recognition awarded by the Malaysian Government through the Bioeconomy Corporation to biotechnology and life sciences companies that meet stringent standards of innovation, quality, and commercial excellence. It signifies a commitment to driving innovation, advancing the bioeconomy, and delivering high-value solutions to the healthcare and biotechnology sectors.
About Precision Diagnostics
Precision Diagnostics is a precision medicine and genomic diagnostics organisation committed to translating advances in genomics into clinically meaningful healthcare solutions supported by clinical governance. Through its work in pharmacogenomics, precision oncology, genomic testing, clinical implementation, and international scientific collaboration, Precision Diagnostics aims to support safer, more personalised, and evidence-based patient care across Malaysia and the Asia-Pacific region.